Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

MediRX vs Steady State Health

MediRX
Graded #206

Higher grade

vs+11.199999999999996
Steady State Health
Graded #451

Lower grade

The verdict

MediRX takes it — 66.1/100 to 54.9/100.

MediRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MediRX is a telehealth weight-loss platform offering compounded GLP-1 injections — semaglutide starting at $149/month and tirzepatide starting at $199/month — plus NAD+ and a name-brand GLP-1 option.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMediRX +19
64
45
Dose & formulationMediRX +37
77
40
Clinical oversightMediRX +4
82
78
Labs & monitoringMediRX +1
53
52
FulfillmentMediRX +8
73
65
Contract termsSteady State Health +35
20
55
MediRX · left barSteady State Health · right bar

The numbers

MetricMediRXSteady State Health
WeighScore66.1/10054.9/100
GradeCC
Scorecard rank#206#451
Semaglutide$149/mo (compounded)Not disclosed
Tirzepatide$199/mo (compounded)Not disclosed
CoverageCoverage not published2 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
MediRX

Graded #206 · C

Strengths

  • LegitScript Certified — a meaningful trust signal for an online pharmacy
  • Named operating entity disclosed (MediRX, Inc., Wyoming)
  • Care and pharmacy fulfillment run on OpenLoop Health's licensed network
  • Low promotional first-month pricing — semaglutide first month as low as $70

Where it loses points

  • Doesn't publish the exact states it serves; telehealth rules vary by state
  • Ongoing monthly price rises after the promotional first month
  • Compounded semaglutide and tirzepatide injections — limited oral options
  • Specific compounding pharmacies aren't named beyond the OpenLoop network
Steady State Health

Graded #451 · C

Strengths

  • Prescribes semaglutide or tirzepatide within a perimenopause and menopause hormone-and-metabolic care plan
  • Care delivered by a named women's-health nurse practitioner (Josie Cowburn, DNP, FNP-C)
  • Transparent flat program fee from $139/mo, with a $99/mo standalone GLP-1 support option

Where it loses points

  • Available only to Oregon and Washington residents
  • GLP-1 medication is billed separately by the pharmacy and not included in the program fee
  • Dispensing pharmacy is not publicly named

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard